Your session is about to expire
← Back to Search
30-day ambulatory cardiac event monitor for Heart Attack (SIMPL-AF Trial)
N/A
Waitlist Available
Led By Jason G Andrade, MD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days and 1-year
Awards & highlights
SIMPL-AF Trial Summary
This trial will compare the rates of new-onset AF in patients who are discharged home in sinus rhythm after a myocardial infarction (MI), with and without an external loop recorder.
Eligible Conditions
- Heart Attack
- Atrial Fibrillation
SIMPL-AF Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days and 1-year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days and 1-year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Incidence of new-onset AF at 30-days post-MI
Secondary outcome measures
AF-related hospitalization
Composite cardiovascular and hospitalization events
Rate of oral anticoagulation
SIMPL-AF Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intensive MonitoringExperimental Treatment1 Intervention
30-day ambulatory cardiac event monitoir
Group II: Standard CareActive Control1 Intervention
Standard Care (no supplemental monitoring)
Find a Location
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,415 Previous Clinical Trials
2,466,776 Total Patients Enrolled
Jason G Andrade, MDPrincipal InvestigatorUniversity of British Columbia
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger